Skip to main content
Livermore
Livermore
ZHEN

US Bancorp

SEC CIK
0000036104
Latest filing
Aug 12, 2026

CLDX holding history

Celldex Therapeutics, Inc. in every 13F filed by US Bancorp, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

CLDX overviewAll 13F holders of CLDXFull Q2 2026 holdings

Shares (Q2 2026)
754
Value
$28.1K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of CLDX by US Bancorp, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026754$28.1K<0.1%−18−2.3%ReducedHolders
Q1 2026772$24.5K<0.1%+50+6.9%AddedHolders
Q4 2025722$19.6K<0.1%00.0%UnchangedHolders
Q3 2025722$18.7K<0.1%−15−2.0%ReducedHolders
Q2 2025737$15.0K<0.1%+485+192.5%AddedHolders
Q1 2025252$4.57K<0.1%−257−50.5%ReducedHolders
Q4 2024509$12.9K<0.1%−173−25.4%ReducedHolders
Q3 2024682$23.2K<0.1%+45+7.1%AddedHolders
Q2 2024637$23.6K<0.1%−33−4.9%ReducedHolders
Q1 2024670$28.1K<0.1%+71+11.9%AddedHolders
Q4 2023599$23.8K<0.1%+480+403.4%AddedHolders
Q3 2023119$3.27K<0.1%−230−65.9%ReducedHolders
Q2 2023349$11.8K<0.1%−57−14.0%ReducedHolders
Q1 2023406$14.6K<0.1%00.0%UnchangedHolders
Q4 2022406$18.1K<0.1%00.0%UnchangedHolders
Q3 2022406$11.0K<0.1%00.0%UnchangedHolders
Q2 2022406$11.0K<0.1%00.0%UnchangedHolders
Q1 2022406$14.0K<0.1%00.0%UnchangedHolders
Q4 2021406$16.0K<0.1%00.0%UnchangedHolders
Q3 2021406$22.0K<0.1%00.0%UnchangedHolders
Q2 2021406$14.0K<0.1%00.0%UnchangedHolders
Q1 2021406$8.00K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.